GLP-1 drugs have suddenly become one of the biggest conversations in health and weight loss, but how much do we actually understand about them? Kevin and Michelle have a candid, sometimes funny conversation about medications like Ozempic and Wegovy, from how GLP-1s work to why they can make such a dramatic difference to appetite and fullness. They dig into the questions that don't always get as much attention: side effects, muscle loss, getting enough protein and nutrients when you're eating much less, the role of resistance training, and what can happen when someone stops taking the medication. They also talk about the growing problem of unauthorized and counterfeit GLP-1 products and why these medications should be treated with the same care as any other prescription drug. There's no blanket “these drugs are good” or “these drugs are bad” verdict here. Instead, the conversation is about being informed, realistic and thoughtful, and recognizing that medication works best alongside good nutrition, exercise and appropriate medical guidance. And since this is just the beginning of the conversation, the hosts want to hear from listeners about their experiences and questions for future expert guests.
Registered Holistic Nutritionist
Michelle specializes in healthy aging, plant-based nutrition, disease prevention and lifestyle change. She translates complex nutrition research into practical strategies listeners can actually use.
Curious Beginner & Co-Host
Kevin asks the questions many listeners are already thinking. He helps make nutrition approachable, relatable and tries to keep things light.
Kevin: Hey, Michelle, I have a question for you.
Michelle: Hey, Kevin, I have an answer.
Kevin: Okay, well, we'll see if you have an answer. It's a really tough question. Okay. Oh, no. Okay. I want you to guess who was the official voice of the launch of Wigovi in India when the Indian government approved Wigovi for personal use.
Michelle: Oh my gosh. How would I know the answer to that? I don't know. Michelle.
Kevin: What? What's my occupation? Oh, no. What is my occupation? No. What is my occupation? Did you forget? Kevin, are you joking me right now? It was you? It was me.
Michelle: Oh, my gosh. I did not know that.
Kevin: So as background for everyone listening, including Michelle, apparently. Yeah. I am a voice actor.
Michelle: Well, I knew that.
Kevin: Well, I don't know. Come on. It was a gimme question.
Michelle: But you said in India. That's what threw me off.
Kevin: Well, with a global economy, people can work from anywhere.
Michelle: Oh, well, true. So you are now a trusted voice in India.
Kevin: I am. I was the hype man behind Wigovi when the Indian Medical Association or whatever it was, the Ministry of Health or whomever in India approved Wigovi. Shut the front door. That was me. How long ago was that? That was about maybe a year ago, maybe a year and a half ago.
Michelle: Wow.
Kevin: Thereabouts.
Michelle: I had no idea.
Kevin: Well, it isn't something that normally comes up in conversation, but it's very appropriate today.
Michelle: No, it doesn't. A year ago, people were not like it wasn't a household term, like people were not asking me about GL1 agonist drugs. And again, just to reiterate for the audience, I'm a registered nutritionist and a nutrition nerd, and I've very vested interest in helping people change their diet lifestyle and get healthier and become informed. I'm not a medical doctor, so I did not know what a GLP1 agonist was. But now I do.
Kevin: Right. Right. Well, it's amazing how quickly these brands like Ozempic and Wigovi and there's a few others have entered the mainstream and entered our consciousness so quickly. It's been such a quick uptake.
Michelle: I think it was celebrities that mostly did it for the mainstream, right?
Kevin: And very good marketing also. I think these companies have done a great job and hired amazing voice actors, by the way.
Michelle: Amazing. The best.
Kevin: Yes. No, but they've done a really good job of getting in people's faces and getting on, you know, getting in their feeds and all that to create awareness and create a bit of a buzz.
Michelle: Yeah. Well, you know, it's a really deeply personal, sensitive topic for so many people. So let's frame things up for the listeners today, Kevin.
Kevin: Yes. We've jumped into this conversation and they have no idea what we're talking about.
Michelle: As we want to do what we want to chat about this a little bit, because I am going to get one or two experts on the pod to to help us unpack this a little bit more from a more scientific, more evidential point of view, a more standard of care, more safety, all of that. But there's so much going on here. And it's not just about a weight loss drug anymore. It's it's it's changing so many aspects of our society. And I just think that you and I have a lot to chat about that, you know, and we want to invite some listener questions. Yes. So let's just level set a couple of things for the audience, because maybe there's people out there that don't actually really know what these drugs are. So GLP-1 receptor agonists are medications that copy the effects of a natural hormone that our bodies already make after we eat. So what that means is that these are these are natural hormones that already occur that control our blood sugar by helping the body respond appropriately after a meal. They help reduce hunger, cravings and appetite by sending stronger signals to to the brain to say, hey, I'm satisfied.
Kevin: OK.
Michelle: And they also slow down digestion so that food stays in that digestive tract longer, stays in our stomach longer.
Kevin: OK, so you feel full longer.
Michelle: Right. So because they imitate the GLP-1 hormone, they can make it easier for some people to eat less and feel more satisfied with less food, while also it can help improve blood sugar control. So these this because of these mechanisms, that's why this drug originally was used for diabetes cases who had issues with blood sugar control and often diabetes patients. Also, you know, obesity is one of the risk factors that can come alongside that with type two diabetics in particular. My understanding is they also were never used in isolation. This was usually just part of a therapy that may have included other diabetes management drugs. So it was just one of the tools in the toolbox. But but this what they found was this this weight loss was so real and so effective and rather fast and helping people control those cravings that it became approved as a weight loss drug, not just a diabetes management drug. So that's sort of the history there. And when we have our expert on, we can we can maybe get a little bit more about that. But this is kind of how this normally works for a human. So you are natural GLP-1 system kicks in when we eat a food after you eat, especially carbohydrates and fats, it moves through our stomach and into the small intestine. And then there are these specialized cells called L cells that are found mainly in the lower part of the small intestine and the large intestine that will detect those nutrients and then release the GLP-1 into the bloodstream. Our body already does this.
Kevin: OK, saying basically, hey, there's food here. Don't sweat it. You're not hungry. Don't eat more.
Michelle: OK, so yeah. So think of it as our body's natural. A meal has arrived. Messenger.
Kevin: It's your gas gauge. It's your body's gas gauge saying, no, the tank is full. No need to no need to go to the gas station right now. Right.
Michelle: Well said. OK, so once released that that GLP-1 hormone can activate the GLP-1 receptors in different tissues. So we have these little so every every hormone has a receptor site. Right. So it fits in a receptor site and that and those exist in many tissues, which is why if you've done any scanning of the media, they're now because these drugs have been so successful. They're investigating their uses for other things.
Kevin: I've heard that. Yes. And some crazy things, too. Yeah.
Michelle: Yeah. So, for example, in the pancreas, it it helps the pancreas release insulin when blood sugar is elevated after eating. And that's the mechanism that helps to move glucose from the bloodstream into the cells, which helps to lower blood sugar. And then in the brain, it contributes to the feelings of satiety. In other words, it signals, hey, we've eaten something and you can start winding down your desire to eat more.
Kevin: I've also heard I don't know how much research has been done yet, but I've also heard that there's apparently a link to GLP-1 and a possible depression.
Michelle: Yeah.
Kevin: Not cure, but but treatment. The depression apparently has some potential link to GLP-1 as as GLP-1 as well. I don't know how far along, but I definitely have heard that.
Michelle: I don't know a lot about this yet either, Kevin. And maybe we file this for our expert. But yeah, I think it has something to do with dopamine release.
Kevin: You're always happy after you eat a big meal. So no, no, no, no. That's that's overly simplifying depression. But it's enough to say that there's a whole bunch of kind of research that's happening with GLP-1 on different on different parts of the that are super complicated organism of the human body.
Michelle: Yeah, exactly. Yeah. And in the stomach, you know, it slows down the movement of food through the stomach, particularly after a meal to make us feel full sooner and longer. And then it also helps to reduce glucagon.
Kevin: Glucagon sounds like a supervillain. Glucagon, you stop that.
Michelle: You always like and whatever, something like that to a supervillain.
Kevin: Because anything that has a silly name.
Michelle: He's such a Marvel kid.
Kevin: I am. I know I was actually always DC. I was more into DC.
Michelle: Oh, OK, fair enough.
Kevin: Glucagon is trying to take over the planet again. Stop that.
Michelle: Well, glucagon is the hormone that tells your liver to release its stored glucose into the bloodstream. So it's another way that it prevents excessively high blood sugar after eating. So these are all good things. And our body already does it.
Kevin: Right, right, right.
Michelle: So so the key difference between natural GLP-1 and the medications is that our body normally produces GLP-1 in response to food. But the natural hormone is broken down very quickly, like within minutes by an enzyme versus the GLP-1 medications are engineered to stay active very much longer. And depending upon the medication, their effects can last anywhere from hours to days. Right. So so, yeah. So in our normal physiology, you eat food, nutrients reach the gut, the L-cells release the GLP-1, the GLP-1 activates receptors, insulin is increases when it's needed, your appetite's reduced, digestion slows and it breaks down. When you have the medication, it activates the exact same receptor, but the effects are longer and longer lasting than the brief natural GLP-1 produced after a meal. That all sounds so good, right? That sounds like, wow, if there I remember being that young woman that would say if there was a pill I could take that would.
Kevin: Yeah. And apparently based on conversations I had with one person, it's a very dramatic feeling like I've never taken a GLP-1. I am not the target audience. You know, for the, you know, all the audience who can't see me, I'm actually like technically on the underweight side of the BMI. So I'm not, I'm not a candidate for this. But apparently like someone who took a very low dose said like within a day they could feel their appetite had been suppressed. And it was, it was noticeable and it was very, very obvious that, you know, they were not hungry and they could eat, you know, like half of what they normally would throughout the day and they still felt very full after eating only half. So apparently, and this was a, a once a week injection. So, and this lasted basically the entire week. So apparently it's a very dramatic feeling that you get and it starts almost immediately.
Michelle: The thing, the thing that I've been reading in, in the evidence, and again, very early for me scanning the evidence to dive into this, this is not a simple rabbit hole that I'm qualified to navigate.
Kevin: Right.
Michelle: But like there are a lot of concerns that first of all, not everyone is going to have that experience that, that your friend had. Like some, some people from what I'm reading, don't lose the weight at all. It just doesn't, it doesn't work for them. And then there's other people that immediately just feel so incredibly ill. There are any drug is going to have side effects, right?
Kevin: Well, I was, I was going to say that like any drug can have, you know, for any drug, it works well for some people. It works mediocre for some people and it can be horrible for some people. So this is, you know, kind of the similar, it's more a matter of, you know, whatever that proportion is with GLP ones.
Michelle: I have absolutely no idea. Nausea, vomiting, diarrhea, and constipation apparently affect roughly 47% to 84% of users.
Kevin: 84%. Oh wow.
Michelle: So yeah, based on some of the studies that they've done so far, that is the most common driver of that category of people that start the drug and then immediately discontinue it. Um, so they say that it drives discontinuation up in about 26% of patients just in the trials alone. Right. And then beyond the nuisance of symptoms, there's apparently accumulating evidence of more serious risks in some people, increased risk of gallbladder or biliary disease and other rare bowel diseases and things like that. But the most common thing that, um, other than, than GI discomfort and managing that, that, that worries medical professionals is that the weight that you lose, the majority of it is not fat. It is muscle mass. And, um, that's why we end up with a zempig face, right? Because a substantial fraction of the weight loss is coming from your lean muscle mass, which is why, um, there are multiple advisory reviews and other reviews that are prioritizing. If you're going to do this, you've got to have an adequate diet to manage this. The one thing that your friend that you mentioned did so well also that is part of this is they call it titrating the drug, how you titrate the drug, either quickly or slowly titrating the drug very slowly is going to help with that as well as the other symptoms from what I've read so far. Um, but also making sure that while you're doing that, you are prioritizing your diet. Now you, you don't normally say this when I'm just generally talking about adopting, you know, healthier, you know, more plant centered eating. I say, don't worry about the protein. You eat a varied diet. You you're hitting the categories. Well, you're getting lots of different types of whole food. The protein kind of takes care of itself. You worry a little bit more if you're going to be doing weight training, resistance training, working out, of course, because you're going to need more of that. But if you're taking a GLP-1 agonist drug, you do need to prioritize adequate protein. You're going to have to then count and make sure if you're plant based, that means lots of legumes, lots of tofu, lots of really rich protein sources. And if you're have a broader diet than that, then making sure that you're getting fish and, you know, prioritize your your white meats. I would still stay away from red meats or keep them very, very low because of the other concerns we've talked about. But you need to make sure that you're getting adequate protein, that you are regularly doing a regimen of resistance training and taking care of all of those micronutrients, your vitamins and your minerals, because people are eating fewer meals and they're eating way less. There's a lot of concern emerging, Kevin, from what I'm reading about nutritional inadequacy. So do you remember me saying in previous when we're just discussing previous topics that we don't typically see kwashiorkor or protein deficiency in our society? We see a lot of nutritional inadequacy, but people who are otherwise have a healthy lifestyle, we don't see that as long as they're getting the food. We're they're now seeing so many concerns about nutritional inadequacy because there is that segment of people that just see this as a quick solution to help me lose weight and where they're instead of their thinking, how can I eat as well as I can in the in the eating opportunities that I now have? They're now thinking, what's my strategy to eat as little as I need to? Right, right. It's kind of messing. I think it's messing with some people's heads a bit.
Kevin: Well, yeah. And it's funny because this this friend who had the very brief doctor's visit, like this person was warned, your muscles are going to suffer or your muscle mass is kind of the, you know, the partial target of these drugs, of the weight loss.
Michelle: I don't really know how I feel about these drugs right now, but I certainly don't have like a blanket. It's bad or it's good. I I'm open to the reality that this could be really appropriate for some people used like medically indicated or, you know, with the proper guidance, the proper titration and the proper guardrails put around it to manage while you're taking the drug with with diet and lifestyle and exercise and all those all those components which seem to be really important.
Kevin: Yeah, I would agree 100 percent. I for me, my concern around this, my I think my only fundamental concern is that I feel there are times with the way it's been marketed and such in the way, you know, it's been talked about and all that. We need to be clear that GLP ones are a drug. They are a medicine, their medication. And you wouldn't take, you know, your heart pills, you know, or or any other medication without fully understanding from your doctor, understanding the risks, understanding, you know, what you can and can't do, etc., etc., etc. And I feel if GLP ones are taken with this background, then that's amazing. But I think when doctors are almost, you know, suggesting GLP ones before the patient mentions it and like otherwise healthy people and again, I'm not talking about people who are massively overweight, but when, you know, in air quotes, healthy people come in for a doctor's appointment and the doctor proactively suggests a GLP one, that's almost taking it out of the drug realm. And it just might be making people take it a little bit too casually and not treating it like the drug that it is. And, you know, I've even heard of, you know, like you can get GLP ones without a prescription. And that's where it scares me a little bit.
Michelle: There are so many websites where you can just go on and there's I mean, it's so easy to make a website nowadays, Kevin, and people say whatever it is. And, you know, you don't really know where these companies come from, but they say, you know, doctor prescribed Health Canada approved and whatever. And I mean, I don't know whether they are or they aren't, but that's my question. Are they? And because I did see Health Canada put out a public advisory in January of this year that says, if you're are you thinking about buying GLP one drugs like Ozempic or Manjaro, beware of fake or unauthorized products. So they've been made aware that there are unauthorized and counterfeit versions of glucagon like peptide one or GLP one receptor agonist drugs. And their advisory is only by prescription drugs from licensed pharmacies. Do not buy or use unauthorized GLP one drugs such as somaglutide or terzepatide.
Kevin: OK, because then tight.
Michelle: Yeah, right. The issue is growing interest in GLP one products such as somaglutide examples, Ozempic, Rebelsis, Wigovi and terzepatide examples are Manjaro and ZepBound for weight loss. Some people may turn to unauthorized or counterfeit products which could pose serious health risks because they have not been appropriately assessed by Health Canada for safety, effectiveness and quality. Health Canada has identified various retailers in Canada selling unauthorized GLP one products both in stores and online through websites. Social media advertisements misuse Health Canada logos. They display fake endorsements to mislead customers. And Health Canada never endorses a health product and does not allow its logo to be used in advertising or packaging of health products. So their worry about this, the risk to the public may include containing too much or too little or none of the active ingredient at all. Right. Containing unlisted, dangerous or unknown ingredients or containing contaminants such as solvents, heavy metal particles such as fibers, glass, plastic or microbials such as bacteria, fungi or endotoxins being poorly or incorrectly labeled or being improperly manufactured or stored. There's there's a lot more to this. This will be just one of many things I give you to put in the show notes, Kevin.
Kevin: Right.
Michelle: That's very, very concerning. So I just want a little bit of a PSA on what people should do if they are looking at these things or they know someone that is. You should only buy your prescription drugs from a licensed pharmacy for all the reasons that you just said. Yes. Do not buy or use any unauthorized products. Look for drugs that have been authorized by Health Canada and verify that by checking the eight digit drug identification number. Every drug has a DIN number, a D-I-N, a drug identification number. Check that number on the label by searching Health Canada's drug product database and talk to your health care professional about it. Even even if you're looking at getting this somewhere else and not from your doctor directly, make your doctor aware, get their advice, know the risks of buying drugs over the Internet and know how to choose a safe online pharmacy. And if you do find yourself, you know, with a health product related side effects or complaints, including suspected counterfeit and unauthorized products, report them. Yes. Report them to Health Canada and see your doctor and see your doctor. And that's why I say go to your doctor and tell them ahead of time, even if you're shy about it. I mean, if something goes wrong, that's who you're going to have to go to anyway. Like so.
Kevin: Yes.
Michelle: Like you can still have agency and make your own decisions, but there's nothing wrong with getting that advice. Right. I'm just it just really worries me, Cap. It worries me.
Kevin: It's a drug like you're not going to it's it you know, you're not going to do this for heart medication or any other serious drug and treat this with the same respect that you would any other drug. And I know that that they can be I think what's driving some of this is, you know, the name brands, as with any drug, are very, very expensive. But there are generics available now and official generics that, you know, have the DIN number you were talking about.
Michelle: Yeah.
Kevin: So just do your homework and treat it with the gravitas that you would treat any other prescription drug because that's what it is. It's a drug.
Michelle: Yeah, so let's take a second, just talk about, you know, sort of what your diet should look like. And this is based on, I did, you know, a wholesome evidence search on this. And so there's a number of sources, credible medical journals. So they all emphasize the same thing, prioritize nutrient density over calorie counting, which is what I always say anyway, right? So actually I was reading this entire list and it's like, that's what I would say anyway. So emphasize minimally processed foods, emphasize fruits, vegetables, whole grains, legumes, lean proteins, et cetera. But you're going to have to construct your meals differently now because we know that this mechanism is going to decrease your appetite and it's going to make you full faster and it's going to make you full longer. That's why you've got to prioritize it. So you want to prioritize your protein up to, because of this muscle mass loss, you're going to want to be, stay between the 1.2, 1.5 grams per kilogram per day. Or if we take Dr. Matt Negra's, you know, popular advice, who really, you know, he really favors, you know, people who work out the 1.6, maybe to two, two grams per kilogram per day, because you are going to be doing that resistance training and working out, right? And consider the sources, macronutrients. So you're going to want to screen for and consider supplementing at risk nutrients such as vitamin D, calcium, B12, iron, potassium. You know what? I would just personally, if it were me, I would just take a really good quality multivitamin mineral supplement in addition to what I'm eating because of those smaller meals, right? Hydration and fiber is still in the forefront. Actually, fiber is one of the key mechanisms that triggers GLP-1 in us naturally, right? OK, so still two to three liters of water a day. And that can include, you know, some coffee and tea as long as you don't put sugar and milk in it. And you're going to need fiber to accompany that because we know that constipation can be one of the side effects of these drugs.
Kevin: And we don't want that.
Michelle: Yeah. And because of side effect mitigation, the evidence in JAMA seems to suggest small, frequent, regularly timed meals, eating slowly, limiting exposures to high fat, fried, spicy sugary foods, carbonated drinks and alcohol. So you're going to have to really watch that GI tolerance bit. And then on the physical activity side, Kevin, just to reiterate, they're saying in this journal to target at least or greater than to 150 minutes per week of moderate intensity aerobic activity, plus two or more sessions per week of resistance training of all of the major muscle groups. And they emphasize that resistance training is the key element for body composition. Yeah. And titrate duration very slowly. Use caution with high intensity exercise, etc. So when we get our medical professional, we can maybe touch on that a bit more. But. You know, I guess what struck me when I read that, not that different, it's it's sounding like what you normally say.
Kevin: So it's like just common sense. Keep on doing that. And yeah, you know, if you treat it with respect that it deserves, then it's not a bad option.
Michelle: And you know, this is where, you know, I might consider, you know, with lots of emphasis on constructing the meals for protein density, but a whole food plant based diet is going to make you feel full slower than having a bunch of meat right in your diet. So keeping those portions small, because I would hate for somebody to do this and fill up on on that meat and then again, be missing out on all of those phytochemicals and micronutrients that they need. Like you can't supplement away a bad diet, right? Thank you. Right. You're still going to need to, even though I would advocate that a multivitamin mineral is going to be a really good idea from what I'm reading so far in that you wouldn't want that to replace actually eating the food. So there's ways to structure that, right? If you're eating smaller, more frequent meals, then then just, you know, plan, plan your meals, plan your day.
Kevin: Exactly. Be aware of what you're eating.
Michelle: You know, one of the things that also that I've, I've heard a couple of people that I've talked to about this say, and I don't know if you've had it with your friends comments like, I only plan to do this for a while because I can't afford to stay on this drug therapy because it's very expensive. Right.
Kevin: I've heard that.
Michelle: Yeah. And I think the caution that I'm seeing in the evidence so far too, from what I know is that that is kind of a misleading goal. I think perhaps because the weight, if you stop taking the drug, two thirds of the weight loss comes back almost immediately.
Kevin: I've, I've heard that the people who use it temporarily, I don't know anyone who's, who's done it. I don't know. None of my contacts have stopped it yet. But I have heard that that's an issue that if you do it temporarily, once you stop taking the GLP ones, obviously that feeling of fullness disappears. And so it's easy to fall back into your previous eating habits, which can be problematic and you can gain that weight back potentially. So it's really potentially no different from any other yo-yo technique that you try and you fail with. So again, have realistic expectations.
Michelle: It's another case for working with the guidance of your primary care professional, which, and perhaps other broader members of your care team, if you do work with a registered nutritionist or a dietician or, and, you know, for your doctor, that can be a medical doctor, like an MD, or that can be a naturopathic doctor. Like they'd all, they'd both be equally qualified, I think, to help guide with that. And then whoever's helping you with your diet and lifestyle strategies. Right. And, and I see in the evidence that discontinuation planning is part of the broader plan. And I think one of those professionals would help you do that. So, so that you avoid the pitfall of just saying, oh, I'm just going to do this for a little while, and then I'm going to stop taking the drug and I will have lost my weight and I can move on. No, it's like any other yo-yo diet scenario that we've seen, right, Kevin? Like, of course, they stop and the weight comes back and sometimes it comes back and then some, if they, if they didn't plan for that or they didn't change their core behaviors. So what does it say here? About half of discontinuance within a year, and those who stop typically regain at least two thirds of the lost weight within one year. Patients stopping should transition to a structured, reduced calorie plan with regular meals, adequate protein, fiber, micronutrients, regular, moderate intensity, self-monitoring, and intensive lifestyle support. So it seems to me, even though this seems like a magic pill, it doesn't seem like a magic pill or injection, however you're getting it.
Kevin: It's just like every other magic diet pill that comes around every few years for the past several decades.
Michelle: Yeah, yeah.
Kevin: But there's always like a downside, and especially when you stop taking it, you run the risk of, you know, bouncing back up.
Michelle: Another thing that's interesting, Kevin, is are you seeing what I'm seeing in the media about how this is changing food, like in general? I've been getting like notifications and, you know, articles from Food Navigator Europe, for example, that those are the sources that talk about the up and coming food innovations and what's happening. Companies are actually tailoring their manufacturer to target a large population that are taking these GLP-1 agonist drugs. So they're designing, for example, protein, fiber, nutrient-centric, tiny meals. Right, and engineering foods and such like that.
Kevin: Because it's a target market opportunity, and I think that that's good so long as they're actually backing up their claims, like so long as this isn't just marketing. But if it's going to deal with the side effects that you'd mentioned, a lot of the GI side effects, and if it's going to make sure that it is dense with nutrients and fiber and protein and all the things that you need that we've spoken about, if it's just marketing fluff that sounds good to appeal to GLP users, then obviously I have an issue with that. You have to know who you're dealing with, and you have to look into it and actually see what the composition is of the food before you actually go ahead and buy it. But I think in theory, that's amazing, given there are these side effects.
Michelle: Well, yeah, you know what? We landed in the same place then, because initially when I saw this, my initial reaction was an eye roll. And then I sat there and I thought about it a bit, and I thought, no, you know what? People are going to have enough trouble. If this is really growing in this space as quickly as it appears to be, and there's that many people that are searching websites and chat GPT and YouTube and TikTok to try to figure out how to navigate this, and they're already perhaps people that have failed on diet and lifestyle interventions in the past, then maybe it's a really good thing that there's going to be people out there designing appropriately portioned, nutrient-dense, well-constructed meal solutions to accompany people on this, because it's not like it's a train that's going to slow down. You know what I mean?
Kevin: Exactly, exactly. So long as the science is there, I'm all for it. Well, thank you, Michelle. This has been very interesting, and I look forward to future guests.
Michelle: Well, thank you. This was just a conversation.
Kevin: Yeah, no, exactly. But it's good to sort of set the baseline for when we have a guest or possibly two in the future to get into the nuts and bolts of it a little bit more and the details of it a bit more.
Michelle: What I would like to ask our listeners, though, Kev, is I'd like to know if you have experiences or you have questions, because I just feel like this is so big and such a very confusing space right now. If you can help us frame these upcoming episodes, we'd love to leverage our experts to answer your questions or hear what you have to say.
Kevin: Yes. So please send us your questions, what you would like to ask one of the experts. You can, of course, email that to us at hello at nutrition for noobs dot com. Michelle loves it when I say the email address like that. And of course, you can get in touch with us. She's giggling in the background. You can get in touch with us on either Facebook or Instagram at nutrition, the number for noobs. And it's time for the dad joke. Oh, yay. So did you hear about the guy who invented Altoids? They said he made a mint.
Michelle: Oh, my gosh, you're crazy.
Kevin: A little bit. OK, and until next time, I will say, as always, eat your greens and be real, everyone. This has been Nutrition for Noobs. We hope you're a bit more enlightened about how your fantastic and complicated body works with the food you put into it. If you haven't already, you can subscribe to the podcast on whatever your favorite platform might be. Also, please consider leaving a review or telling your friends. That's the best way to spread the word. We'll see you next time with another interesting topic. The views and opinions expressed on Nutrition for Noobs are those of the hosts. It is not intended to be a substitute for medical, nutritional or health advice. Listeners should seek a personal consultation with a qualified practitioner if they have any concerns or before commencing any actions mentioned in the podcast.
Michelle: Like I would just hate I would hate to see that for people, especially people that I care about and know personally, I would hate to have them.
Kevin: But strangers who don't care, they a stranger can like, whatever, go ahead, balloon up again.
Michelle: I don't care.
Kevin: But people I like and care about.
Subscribe wherever you get your podcasts and never miss an episode. Evidence-based nutrition, practical advice and the occasional dad joke, delivered every two weeks.